Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
5.69
-0.11 (-1.90%)
At close: Oct 03, 2025, 3:59 PM
6.00
5.45%
Pre-market: Oct 06, 2025, 09:19 AM EDT
Cellectar Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -29.07M | -24.54M | -44.58M | -49.67M | -52.53M | -61.79M | -42.34M | -42.1M | -32.4M | -29.65M | -28.6M | -27.3M | -25.31M | -23.9M | -24.12M | -21.82M | -19.91M | -17.49M |
Depreciation & Amortization | 249K | 259.46K | 291.65K | 293.04K | 265.68K | 238.31K | 192.38K | 160.57K | 152.33K | 147.57K | 148.44K | 149.57K | 153.4K | 158.2K | 149.91K | 146.55K | 145.69K | 142.65K |
Stock-Based Compensation | 4.15M | 4.38M | 4.27M | 3.87M | 2.84M | 2.46M | 2.41M | 1.69M | 1.56M | 1.56M | 1.45M | 1.47M | 1.52M | 1.3M | 1.12M | 860.8K | 555.93K | 447.96K |
Other Working Capital | -1.4M | -3.24M | -1.73M | -78.89K | -1.56M | 306.12K | 3.48M | 1.27M | 906.15K | 1.9M | 1.68M | 3.27M | 1.81M | -493.44K | 198.76K | -1.01M | 319.11K | 1.84M |
Other Non-Cash Items | -8.5M | -20.46M | -5.84M | -676.76K | 5.82M | 20.23M | 3.88M | 8.79M | 641.55K | -1.32M | 93.82K | 90.49K | 87.27K | 80.76K | 80.66K | -107.56K | -110.42K | -113.19K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.4M | -3.24M | -1.73M | -78.89K | -1.56M | 306.12K | 3.48M | 1.27M | 906.15K | 1.9M | 1.68M | 3.27M | 1.81M | -493.44K | 198.76K | -1.01M | 319.11K | 1.84M |
Operating Cash Flow | -34.58M | -43.6M | -47.58M | -46.27M | -45.17M | -38.55M | -32.38M | -30.19M | -29.14M | -27.37M | -25.22M | -22.32M | -21.74M | -22.86M | -22.57M | -21.93M | -19M | -15.17M |
Capital Expenditures | -61.29K | -82.56K | -104.19K | -309.67K | -906.95K | -885.67K | -864.04K | -715.14K | -124.92K | -195.9K | -225.97K | -237.85K | -234.85K | -171.43K | -141.36K | -28.83K | -24.77K | -51.8K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -61.29K | -82.56K | -104.19K | -309.67K | -906.95K | -885.67K | -864.04K | -715.14K | -124.92K | -195.9K | -225.97K | -237.85K | -234.85K | -171.43K | -141.36K | -28.83K | -24.77K | -51.8K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 184K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19.81M | 17.56M | 61.41M | 61.85M | 66.79M | 66.79M | 22.94M | 22.5M | 3.00 | 3.00 | n/a | n/a | n/a | 34.87K | 1.25M | 2M | 1.89M | 20.11M |
Financial Cash Flow | 19.81M | 17.56M | 61.41M | 61.85M | 66.79M | 66.79M | 22.94M | 32.11M | 9.61M | 9.61M | 9.61M | n/a | n/a | 34.87K | 1.25M | 43.46M | 43.35M | 61.76M |
Net Cash Flow | -14.83M | -26.13M | 13.72M | 15.28M | 20.72M | 27.35M | -10.3M | 1.2M | -19.65M | -17.95M | -15.84M | -22.56M | -21.97M | -22.99M | -21.46M | 21.5M | 24.33M | 46.53M |
Free Cash Flow | -34.64M | -43.69M | -47.69M | -46.57M | -46.07M | -39.44M | -33.24M | -30.91M | -29.26M | -27.56M | -25.45M | -22.56M | -21.97M | -23.03M | -22.71M | -21.96M | -19.02M | -15.23M |